0 Votes

Changes for page Research at a Glance

Last modified by Ryan C on 2025/06/26 03:09

From version 72.1
edited by Ryan C
on 2025/03/16 05:13
Change comment: There is no comment for this version
To version 70.1
edited by Ryan C
on 2025/03/16 03:56
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -1203,329 +1203,77 @@
1203 1203  
1204 1204  {{html}}<hr style="border: 3px solid red;">{{/html}}
1205 1205  
1206 -
1207 -
1208 -{{expand title="Study: Racial Bias in Pain Assessment and Treatment Recommendations" expanded="false"}}
1209 -**Source:** *Proceedings of the National Academy of Sciences (PNAS)*
1210 -**Date of Publication:** *2016*
1211 -**Author(s):** *Kelly M. Hoffman, Sophie Trawalter, Jordan R. Axta, M. Norman Oliver*
1212 -**Title:** *"Racial Bias in Pain Assessment and Treatment Recommendations, and False Beliefs About Biological Differences Between Blacks and Whites"*
1213 -**DOI:** [10.1073/pnas.1516047113](https://doi.org/10.1073/pnas.1516047113)
1214 -**Subject Matter:** *Health Disparities, Racial Bias, Medical Treatment*
1215 -
1216 ----
1217 -
1218 -## **Key Statistics**
1219 -1. **General Observations:**
1220 - - Study analyzed **racial disparities in pain perception and treatment recommendations**.
1221 - - Found that **white laypeople and medical students endorsed false beliefs about biological differences** between Black and white individuals.
1222 -
1223 -2. **Subgroup Analysis:**
1224 - - **50% of medical students surveyed endorsed at least one false belief about biological differences**.
1225 - - Participants who held these false beliefs were **more likely to underestimate Black patients’ pain levels**.
1226 -
1227 -3. **Other Significant Data Points:**
1228 - - **Black patients were less likely to receive appropriate pain treatment** compared to white patients.
1229 - - The study confirmed that **historical misconceptions about racial differences still persist in modern medicine**.
1230 -
1231 ----
1232 -
1233 -## **Findings**
1234 -1. **Primary Observations:**
1235 - - False beliefs about biological racial differences **correlate with racial disparities in pain treatment**.
1236 - - Medical students and residents who endorsed these beliefs **showed greater racial bias in treatment recommendations**.
1237 -
1238 -2. **Subgroup Trends:**
1239 - - Physicians who **did not endorse these beliefs** showed **no racial bias** in treatment recommendations.
1240 - - Bias was **strongest among first-year medical students** and decreased slightly in later years of training.
1241 -
1242 -3. **Specific Case Analysis:**
1243 - - Study participants **underestimated Black patients' pain and recommended less effective pain treatments**.
1244 - - The study suggests that **racial disparities in medical care stem, in part, from these enduring false beliefs**.
1245 -
1246 ----
1247 -
1248 -## **Critique and Observations**
1249 -1. **Strengths of the Study:**
1250 - - **First empirical study to connect false racial beliefs with medical decision-making**.
1251 - - Utilizes a **large sample of medical students and residents** from diverse institutions.
1252 -
1253 -2. **Limitations of the Study:**
1254 - - The study focuses on **Black vs. white disparities**, leaving other racial/ethnic groups unexplored.
1255 - - Participants' responses were based on **hypothetical medical cases, not real-world treatment decisions**.
1256 -
1257 -3. **Suggestions for Improvement:**
1258 - - Future research should examine **how these biases manifest in real clinical settings**.
1259 - - Investigate **whether medical training can correct these biases over time**.
1260 -
1261 ----
1262 -
1263 -## **Relevance to Subproject**
1264 -- Highlights **racial disparities in healthcare**, specifically in pain assessment and treatment.
1265 -- Supports **research on implicit bias and its impact on medical outcomes**.
1266 -- Provides evidence for **the need to address racial bias in medical education**.
1267 -
1268 ----
1269 -
1270 -## **Suggestions for Further Exploration**
1271 -1. Investigate **interventions to reduce racial bias in medical decision-making**.
1272 -2. Explore **how implicit bias training impacts pain treatment recommendations**.
1273 -3. Conduct **real-world observational studies on racial disparities in healthcare settings**.
1274 -
1275 ----
1276 -
1277 -## **Summary of Research Study**
1278 -This study examines **racial bias in pain perception and treatment** among **white laypeople and medical professionals**, demonstrating that **false beliefs about biological differences contribute to disparities in pain management**. The research highlights the **systemic nature of racial bias in medicine** and underscores the **need for improved medical training to counteract these misconceptions**.
1279 -
1280 -This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1281 -
1282 ----
1283 -
1284 -## **📄 Download Full Study**
1285 -[[Download Full Study>>attach:10.1073_pnas.1516047113.pdf]]
1286 -
1287 -{{/expand}}
1288 -
1289 -{{html}}<hr style="border: 3px solid red;">{{/html}}
1290 -
1291 -
1292 -{{expand title="Study: Rising Morbidity and Mortality in Midlife Among White Non-Hispanic Americans" expanded="false"}}
1293 -**Source:** *Proceedings of the National Academy of Sciences (PNAS)*
1294 -**Date of Publication:** *2015*
1295 -**Author(s):** *Anne Case, Angus Deaton*
1296 -**Title:** *"Rising Morbidity and Mortality in Midlife Among White Non-Hispanic Americans in the 21st Century"*
1297 -**DOI:** [10.1073/pnas.1518393112](https://doi.org/10.1073/pnas.1518393112)
1298 -**Subject Matter:** *Public Health, Mortality, Socioeconomic Factors*
1299 -
1300 ----
1301 -
1302 -## **Key Statistics**
1303 -1. **General Observations:**
1304 - - Mortality rates among **middle-aged white non-Hispanic Americans (ages 45–54)** increased from 1999 to 2013.
1305 - - This reversal in mortality trends is unique to the U.S.; **no other wealthy country experienced a similar rise**.
1306 -
1307 -2. **Subgroup Analysis:**
1308 - - The increase was **most pronounced among those with a high school education or less**.
1309 - - Hispanic and Black non-Hispanic mortality continued to decline over the same period.
1310 -
1311 -3. **Other Significant Data Points:**
1312 - - Rising mortality was driven primarily by **suicide, drug and alcohol poisoning, and chronic liver disease**.
1313 - - Midlife morbidity increased as well, with more reports of **poor health, pain, and mental distress**.
1314 -
1315 ----
1316 -
1317 -## **Findings**
1318 -1. **Primary Observations:**
1319 - - The rise in mortality is attributed to **substance abuse, economic distress, and deteriorating mental health**.
1320 - - The increase in **suicides and opioid overdoses parallels broader socioeconomic decline**.
1321 -
1322 -2. **Subgroup Trends:**
1323 - - The **largest mortality increases** occurred among **whites without a college degree**.
1324 - - Chronic pain, functional limitations, and self-reported mental distress **rose significantly in affected groups**.
1325 -
1326 -3. **Specific Case Analysis:**
1327 - - **Educational attainment was a major predictor of mortality trends**, with better-educated individuals experiencing lower mortality rates.
1328 - - Mortality among **white Americans with a college degree continued to decline**, resembling trends in other wealthy nations.
1329 -
1330 ----
1331 -
1332 -## **Critique and Observations**
1333 -1. **Strengths of the Study:**
1334 - - **First major study to highlight rising midlife mortality among U.S. whites**.
1335 - - Uses **CDC and Census mortality data spanning over a decade**.
1336 -
1337 -2. **Limitations of the Study:**
1338 - - Does not establish **causality** between economic decline and increased mortality.
1339 - - Lacks **granular data on opioid prescribing patterns and regional differences**.
1340 -
1341 -3. **Suggestions for Improvement:**
1342 - - Future studies should explore **how economic shifts, healthcare access, and mental health treatment contribute to these trends**.
1343 - - Further research on **racial and socioeconomic disparities in mortality trends** is needed.
1344 -
1345 ----
1346 -
1347 -## **Relevance to Subproject**
1348 -- Highlights **socioeconomic and racial disparities** in health outcomes.
1349 -- Supports research on **substance abuse and mental health crises in the U.S.**.
1350 -- Provides evidence for **the role of economic instability in public health trends**.
1351 -
1352 ----
1353 -
1354 -## **Suggestions for Further Exploration**
1355 -1. Investigate **regional differences in rising midlife mortality**.
1356 -2. Examine the **impact of the opioid crisis on long-term health trends**.
1357 -3. Study **policy interventions aimed at reversing rising mortality rates**.
1358 -
1359 ----
1360 -
1361 -## **Summary of Research Study**
1362 -This study documents a **reversal in mortality trends among middle-aged white non-Hispanic Americans**, showing an increase in **suicide, drug overdoses, and alcohol-related deaths** from 1999 to 2013. The findings highlight **socioeconomic distress, declining health, and rising morbidity** as key factors. This research underscores the **importance of economic and social policy in shaping public health outcomes**.
1363 -
1364 -This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1365 -
1366 ----
1367 -
1368 -## **📄 Download Full Study**
1369 -[[Download Full Study>>attach:10.1073_pnas.1518393112.pdf]]
1370 -
1371 -{{/expand}}
1372 -
1373 -{{html}}<hr style="border: 3px solid red;">{{/html}}
1374 -
1375 -{{expand title="Study: How Do People Without Migration Background Experience and Impact Today’s Superdiverse Cities?" expanded="false"}}
1376 -**Source:** *Journal of Ethnic and Migration Studies*
1377 -**Date of Publication:** *2023*
1378 -**Author(s):** *Maurice Crul, Frans Lelie, Elif Keskiner, Laure Michon, Ismintha Waldring*
1379 -**Title:** *"How Do People Without Migration Background Experience and Impact Today’s Superdiverse Cities?"*
1380 -**DOI:** [10.1080/1369183X.2023.2182548](https://doi.org/10.1080/1369183X.2023.2182548)
1381 -**Subject Matter:** *Urban Sociology, Migration Studies, Integration*
1382 -
1383 ----
1384 -
1385 -## **Key Statistics**
1386 -1. **General Observations:**
1387 - - Study examines the role of **people without migration background** in majority-minority cities.
1388 - - Analyzes **over 3,000 survey responses and 150 in-depth interviews** from six North-Western European cities.
1389 -
1390 -2. **Subgroup Analysis:**
1391 - - Explores differences in **integration, social interactions, and perceptions of diversity**.
1392 - - Studies how **class, education, and neighborhood composition** affect adaptation to urban diversity.
1393 -
1394 -3. **Other Significant Data Points:**
1395 - - The study introduces the **Becoming a Minority (BaM) project**, a large-scale investigation of urban demographic shifts.
1396 - - **People without migration background perceive diversity differently**, with some embracing and others resisting change.
1397 -
1398 ----
1399 -
1400 -## **Findings**
1401 -1. **Primary Observations:**
1402 - - The study **challenges traditional integration theories**, arguing that non-migrant groups also undergo adaptation processes.
1403 - - Some residents **struggle with demographic changes**, while others see diversity as an asset.
1404 -
1405 -2. **Subgroup Trends:**
1406 - - Young, educated individuals in urban areas **are more open to cultural diversity**.
1407 - - Older and less mobile residents **report feelings of displacement and social isolation**.
1408 -
1409 -3. **Specific Case Analysis:**
1410 - - Examines how **people without migration background navigate majority-minority settings** in cities like Amsterdam and Vienna.
1411 - - Analyzes **whether former ethnic majority groups now perceive themselves as minorities**.
1412 -
1413 ----
1414 -
1415 -## **Critique and Observations**
1416 -1. **Strengths of the Study:**
1417 - - **Innovative approach** by examining the impact of migration on native populations.
1418 - - Uses **both qualitative and quantitative data** for robust analysis.
1419 -
1420 -2. **Limitations of the Study:**
1421 - - Limited to **Western European urban settings**, missing perspectives from other global regions.
1422 - - Does not fully explore **policy interventions for fostering social cohesion**.
1423 -
1424 -3. **Suggestions for Improvement:**
1425 - - Expand research to **other geographical contexts** to understand migration effects globally.
1426 - - Investigate **long-term trends in urban adaptation and community building**.
1427 -
1428 ----
1429 -
1430 -## **Relevance to Subproject**
1431 -- Provides a **new perspective on urban integration**, shifting focus from migrants to native-born populations.
1432 -- Highlights the **role of social and economic power in shaping urban diversity outcomes**.
1433 -- Challenges existing **assimilation theories by showing bidirectional adaptation in diverse cities**.
1434 -
1435 ----
1436 -
1437 -## **Suggestions for Further Exploration**
1438 -1. Study how **local policies shape attitudes toward urban diversity**.
1439 -2. Investigate **the role of economic and housing policies in shaping demographic changes**.
1440 -3. Explore **how social networks influence perceptions of migration and diversity**.
1441 -
1442 ----
1443 -
1444 -## **Summary of Research Study**
1445 -This study examines how **people without migration background experience demographic change in majority-minority cities**. Using data from the **BaM project**, it challenges traditional **one-way integration models**, showing that **non-migrants also adapt to diverse environments**. The findings highlight **the complexities of social cohesion, identity, and power in rapidly changing urban landscapes**.
1446 -
1447 -This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1448 -
1449 ----
1450 -
1451 -## **📄 Download Full Study**
1452 -[[Download Full Study>>attach:10.1080_1369183X.2023.2182548.pdf]]
1453 -
1454 -{{/expand}}
1455 -
1456 -{{html}}<hr style="border: 3px solid red;">{{/html}}
1457 -
1458 -{{expand title="Study: Factors Associated with Completion of a Drug Treatment Court Diversion Program" expanded="false"}}
1459 -**Source:** *Substance Use & Misuse*
1206 +{{expand title="Study: Genetic Analysis of African Populations: Human Evolution and Complex Disease" expanded="false"}}
1207 +**Source:** *Nature Reviews Genetics*
1460 1460  **Date of Publication:** *2002*
1461 -**Author(s):** *Clifford A. Butzin, Christine A. Saum, Frank R. Scarpitti*
1462 -**Title:** *"Factors Associated with Completion of a Drug Treatment Court Diversion Program"*
1463 -**DOI:** [10.1081/JA-120014424](https://doi.org/10.1081/JA-120014424)
1464 -**Subject Matter:** *Substance Use, Criminal Justice, Drug Courts*
1209 +**Author(s):** *Sarah A. Tishkoff, Scott M. Williams*
1210 +**Title:** *"Genetic Analysis of African Populations: Human Evolution and Complex Disease"*
1211 +**DOI:** [10.1038/nrg865](https://doi.org/10.1038/nrg865)
1212 +**Subject Matter:** *Population Genetics, Human Evolution, Complex Diseases*
1465 1465  
1466 1466  ---
1467 1467  
1468 1468  ## **Key Statistics**
1469 1469  1. **General Observations:**
1470 - - Study examined **drug treatment court success rates** among first-time offenders.
1471 - - Strongest predictors of **successful completion were employment status and race**.
1218 + - Africa harbors **the highest genetic diversity** of any region, making it key to understanding human evolution.
1219 + - The study analyzes **genetic variation and linkage disequilibrium (LD) in African populations**.
1472 1472  
1473 1473  2. **Subgroup Analysis:**
1474 - - Individuals with **stable jobs were more likely to complete the program**.
1475 - - **Black participants had lower success rates**, suggesting potential systemic disparities.
1222 + - African populations exhibit **greater genetic differentiation compared to non-Africans**.
1223 + - **Migration and admixture** have shaped modern African genomes over the past **100,000 years**.
1476 1476  
1477 1477  3. **Other Significant Data Points:**
1478 - - **Education level was positively correlated** with program completion.
1479 - - Frequency of **drug use before enrollment affected treatment outcomes**.
1226 + - The **effective population size (Ne) of Africans** is higher than that of non-African populations.
1227 + - LD blocks are **shorter in African genomes**, suggesting more historical recombination events.
1480 1480  
1481 1481  ---
1482 1482  
1483 1483  ## **Findings**
1484 1484  1. **Primary Observations:**
1485 - - **Social stability factors** (employment, education) were key to treatment success.
1486 - - **Race and pre-existing substance use patterns** influenced completion rates.
1233 + - African populations are the **most genetically diverse**, supporting the *Recent African Origin* hypothesis.
1234 + - Genetic variation in African populations can **help fine-map complex disease genes**.
1487 1487  
1488 1488  2. **Subgroup Trends:**
1489 - - White offenders had **higher completion rates** than Black offenders.
1490 - - Drug court success was **higher for those with lower initial drug use frequency**.
1237 + - **West Africans exhibit higher genetic diversity** than East Africans due to differing migration patterns.
1238 + - Populations such as **San hunter-gatherers show deep genetic divergence**.
1491 1491  
1492 1492  3. **Specific Case Analysis:**
1493 - - **Individuals with strong social ties were more likely to finish the program**.
1494 - - Success rates were **significantly higher for participants with case management support**.
1241 + - Admixture in African Americans includes **West African and European genetic contributions**.
1242 + - SNP (single nucleotide polymorphism) diversity in African genomes **exceeds that of non-African groups**.
1495 1495  
1496 1496  ---
1497 1497  
1498 1498  ## **Critique and Observations**
1499 1499  1. **Strengths of the Study:**
1500 - - **First empirical study on drug court program success factors**.
1501 - - Uses **longitudinal data** for post-treatment analysis.
1248 + - Provides **comprehensive genetic analysis** of diverse African populations.
1249 + - Highlights **how genetic diversity impacts health disparities and disease risks**.
1502 1502  
1503 1503  2. **Limitations of the Study:**
1504 - - Lacks **qualitative data on personal motivation and treatment engagement**.
1505 - - Focuses on **short-term program success** without tracking **long-term relapse rates**.
1252 + - Many **African populations remain understudied**, limiting full understanding of diversity.
1253 + - Focuses more on genetic variation than on **specific disease mechanisms**.
1506 1506  
1507 1507  3. **Suggestions for Improvement:**
1508 - - Future research should examine **racial disparities in drug court outcomes**.
1509 - - Study **how community resources impact long-term recovery**.
1256 + - Expand research into **underrepresented African populations**.
1257 + - Integrate **whole-genome sequencing for a more detailed evolutionary timeline**.
1510 1510  
1511 1511  ---
1512 1512  
1513 1513  ## **Relevance to Subproject**
1514 -- Provides insight into **what factors contribute to drug court program success**.
1515 -- Highlights **racial disparities in criminal justice-based rehabilitation programs**.
1516 -- Supports **policy discussions on improving access to drug treatment for marginalized groups**.
1262 +- Supports **genetic models of human evolution** and the **out-of-Africa hypothesis**.
1263 +- Reinforces **Africa’s key role in disease gene mapping and precision medicine**.
1264 +- Provides insight into **historical migration patterns and their genetic impact**.
1517 1517  
1518 1518  ---
1519 1519  
1520 1520  ## **Suggestions for Further Exploration**
1521 -1. Investigate **the role of mental health in drug court success rates**.
1522 -2. Assess **long-term relapse prevention strategies post-treatment**.
1523 -3. Explore **alternative diversion programs beyond traditional drug courts**.
1269 +1. Investigate **genetic adaptations to local environments within Africa**.
1270 +2. Study **the role of African genetic diversity in disease resistance**.
1271 +3. Expand research on **how ancient migration patterns shaped modern genetic structure**.
1524 1524  
1525 1525  ---
1526 1526  
1527 1527  ## **Summary of Research Study**
1528 -This study examines **factors influencing the completion of drug treatment court programs**, identifying **employment, education, and race as key predictors**. The research underscores **systemic disparities in drug court outcomes**, emphasizing the need for **improved support systems for at-risk populations**.
1276 +This study explores the **genetic diversity of African populations**, analyzing their role in **human evolution and complex disease research**. The findings highlight **Africa’s unique genetic landscape**, confirming it as the most genetically diverse continent. The research provides valuable insights into **how genetic variation influences disease susceptibility, evolution, and population structure**.
1529 1529  
1530 1530  This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1531 1531  
... ... @@ -1532,7 +1532,7 @@
1532 1532  ---
1533 1533  
1534 1534  ## **📄 Download Full Study**
1535 -[[Download Full Study>>attach:10.1081_JA-120014424.pdf]]
1283 +[[Download Full Study>>attach:10.1038_nrg865MODERN.pdf]]
1536 1536  
1537 1537  {{/expand}}
1538 1538  
... ... @@ -1539,252 +1539,4 @@
1539 1539  {{html}}<hr style="border: 3px solid red;">{{/html}}
1540 1540  
1541 1541  
1542 -{{expand title="Study: Cross-Cultural Sources of Measurement Error in Substance Use Surveys" expanded="false"}}
1543 -**Source:** *Substance Use & Misuse*
1544 -**Date of Publication:** *2003*
1545 -**Author(s):** *Timothy P. Johnson, Phillip J. Bowman*
1546 -**Title:** *"Cross-Cultural Sources of Measurement Error in Substance Use Surveys"*
1547 -**DOI:** [10.1081/JA-120023394](https://doi.org/10.1081/JA-120023394)
1548 -**Subject Matter:** *Survey Methodology, Racial Disparities, Substance Use Research*
1549 1549  
1550 ----
1551 -
1552 -## **Key Statistics**
1553 -1. **General Observations:**
1554 - - Study examined **how racial and cultural factors influence self-reported substance use data**.
1555 - - Analyzed **36 empirical studies from 1977–2003** on survey reliability across racial/ethnic groups.
1556 -
1557 -2. **Subgroup Analysis:**
1558 - - Black and Latino respondents **were more likely to underreport drug use** compared to White respondents.
1559 - - **Cultural stigma and distrust in research institutions** affected self-report accuracy.
1560 -
1561 -3. **Other Significant Data Points:**
1562 - - **Surveys using biological validation (urinalysis, hair tests) revealed underreporting trends**.
1563 - - **Higher recantation rates** (denying past drug use) were observed among minority respondents.
1564 -
1565 ----
1566 -
1567 -## **Findings**
1568 -1. **Primary Observations:**
1569 - - Racial/ethnic disparities in **substance use reporting bias survey-based research**.
1570 - - **Social desirability and cultural norms impact data reliability**.
1571 -
1572 -2. **Subgroup Trends:**
1573 - - White respondents were **more likely to overreport** substance use.
1574 - - Black and Latino respondents **had higher recantation rates**, particularly in face-to-face interviews.
1575 -
1576 -3. **Specific Case Analysis:**
1577 - - Mode of survey administration **significantly influenced reporting accuracy**.
1578 - - **Self-administered surveys produced more reliable data than interviewer-administered surveys**.
1579 -
1580 ----
1581 -
1582 -## **Critique and Observations**
1583 -1. **Strengths of the Study:**
1584 - - **Comprehensive review of 36 studies** on measurement error in substance use reporting.
1585 - - Identifies **systemic biases affecting racial/ethnic survey reliability**.
1586 -
1587 -2. **Limitations of the Study:**
1588 - - Relies on **secondary data analysis**, limiting direct experimental control.
1589 - - Does not explore **how measurement error impacts policy decisions**.
1590 -
1591 -3. **Suggestions for Improvement:**
1592 - - Future research should **incorporate mixed-method approaches** (qualitative & quantitative).
1593 - - Investigate **how survey design can reduce racial reporting disparities**.
1594 -
1595 ----
1596 -
1597 -## **Relevance to Subproject**
1598 -- Supports research on **racial disparities in self-reported health behaviors**.
1599 -- Highlights **survey methodology issues that impact substance use epidemiology**.
1600 -- Provides insights for **improving data accuracy in public health research**.
1601 -
1602 ----
1603 -
1604 -## **Suggestions for Further Exploration**
1605 -1. Investigate **how survey design impacts racial disparities in self-reported health data**.
1606 -2. Study **alternative data collection methods (biometric validation, passive data tracking)**.
1607 -3. Explore **the role of social stigma in self-reported health behaviors**.
1608 -
1609 ----
1610 -
1611 -## **Summary of Research Study**
1612 -This study examines **cross-cultural biases in self-reported substance use surveys**, showing that **racial/ethnic minorities are more likely to underreport drug use** due to **social stigma, research distrust, and survey administration methods**. The findings highlight **critical issues in public health data collection and the need for improved survey design**.
1613 -
1614 -This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1615 -
1616 ----
1617 -
1618 -## **📄 Download Full Study**
1619 -[[Download Full Study>>attach:10.1081_JA-120023394.pdf]]
1620 -
1621 -{{/expand}}
1622 -
1623 -{{html}}<hr style="border: 3px solid red;">{{/html}}
1624 -
1625 -{{expand title="Study: Cross-Cultural Sources of Measurement Error in Substance Use Surveys" expanded="false"}}
1626 -**Source:** *Substance Use & Misuse*
1627 -**Date of Publication:** *2003*
1628 -**Author(s):** *Timothy P. Johnson, Phillip J. Bowman*
1629 -**Title:** *"Cross-Cultural Sources of Measurement Error in Substance Use Surveys"*
1630 -**DOI:** [10.1081/JA-120023394](https://doi.org/10.1081/JA-120023394)
1631 -**Subject Matter:** *Survey Methodology, Racial Disparities, Substance Use Research*
1632 -
1633 ----
1634 -
1635 -## **Key Statistics**
1636 -1. **General Observations:**
1637 - - Study examined **how racial and cultural factors influence self-reported substance use data**.
1638 - - Analyzed **36 empirical studies from 1977–2003** on survey reliability across racial/ethnic groups.
1639 -
1640 -2. **Subgroup Analysis:**
1641 - - Black and Latino respondents **were more likely to underreport drug use** compared to White respondents.
1642 - - **Cultural stigma and distrust in research institutions** affected self-report accuracy.
1643 -
1644 -3. **Other Significant Data Points:**
1645 - - **Surveys using biological validation (urinalysis, hair tests) revealed underreporting trends**.
1646 - - **Higher recantation rates** (denying past drug use) were observed among minority respondents.
1647 -
1648 ----
1649 -
1650 -## **Findings**
1651 -1. **Primary Observations:**
1652 - - Racial/ethnic disparities in **substance use reporting bias survey-based research**.
1653 - - **Social desirability and cultural norms impact data reliability**.
1654 -
1655 -2. **Subgroup Trends:**
1656 - - White respondents were **more likely to overreport** substance use.
1657 - - Black and Latino respondents **had higher recantation rates**, particularly in face-to-face interviews.
1658 -
1659 -3. **Specific Case Analysis:**
1660 - - Mode of survey administration **significantly influenced reporting accuracy**.
1661 - - **Self-administered surveys produced more reliable data than interviewer-administered surveys**.
1662 -
1663 ----
1664 -
1665 -## **Critique and Observations**
1666 -1. **Strengths of the Study:**
1667 - - **Comprehensive review of 36 studies** on measurement error in substance use reporting.
1668 - - Identifies **systemic biases affecting racial/ethnic survey reliability**.
1669 -
1670 -2. **Limitations of the Study:**
1671 - - Relies on **secondary data analysis**, limiting direct experimental control.
1672 - - Does not explore **how measurement error impacts policy decisions**.
1673 -
1674 -3. **Suggestions for Improvement:**
1675 - - Future research should **incorporate mixed-method approaches** (qualitative & quantitative).
1676 - - Investigate **how survey design can reduce racial reporting disparities**.
1677 -
1678 ----
1679 -
1680 -## **Relevance to Subproject**
1681 -- Supports research on **racial disparities in self-reported health behaviors**.
1682 -- Highlights **survey methodology issues that impact substance use epidemiology**.
1683 -- Provides insights for **improving data accuracy in public health research**.
1684 -
1685 ----
1686 -
1687 -## **Suggestions for Further Exploration**
1688 -1. Investigate **how survey design impacts racial disparities in self-reported health data**.
1689 -2. Study **alternative data collection methods (biometric validation, passive data tracking)**.
1690 -3. Explore **the role of social stigma in self-reported health behaviors**.
1691 -
1692 ----
1693 -
1694 -## **Summary of Research Study**
1695 -This study examines **cross-cultural biases in self-reported substance use surveys**, showing that **racial/ethnic minorities are more likely to underreport drug use** due to **social stigma, research distrust, and survey administration methods**. The findings highlight **critical issues in public health data collection and the need for improved survey design**.
1696 -
1697 -This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1698 -
1699 ----
1700 -
1701 -## **📄 Download Full Study**
1702 -[[Download Full Study>>attach:10.1081_JA-120023394.pdf]]
1703 -
1704 -{{/expand}}
1705 -
1706 -{{html}}<hr style="border: 3px solid red;">{{/html}}
1707 -
1708 -{{expand title="Study: Factors Associated with Completion of a Drug Treatment Court Diversion Program" expanded="false"}}
1709 -**Source:** *Substance Use & Misuse*
1710 -**Date of Publication:** *2002*
1711 -**Author(s):** *Clifford A. Butzin, Christine A. Saum, Frank R. Scarpitti*
1712 -**Title:** *"Factors Associated with Completion of a Drug Treatment Court Diversion Program"*
1713 -**DOI:** [10.1081/JA-120014424](https://doi.org/10.1081/JA-120014424)
1714 -**Subject Matter:** *Substance Use, Criminal Justice, Drug Courts*
1715 -
1716 ----
1717 -
1718 -## **Key Statistics**
1719 -1. **General Observations:**
1720 - - Study examined **drug treatment court success rates** among first-time offenders.
1721 - - Strongest predictors of **successful completion were employment status and race**.
1722 -
1723 -2. **Subgroup Analysis:**
1724 - - Individuals with **stable jobs were more likely to complete the program**.
1725 - - **Black participants had lower success rates**, suggesting potential systemic disparities.
1726 -
1727 -3. **Other Significant Data Points:**
1728 - - **Education level was positively correlated** with program completion.
1729 - - Frequency of **drug use before enrollment affected treatment outcomes**.
1730 -
1731 ----
1732 -
1733 -## **Findings**
1734 -1. **Primary Observations:**
1735 - - **Social stability factors** (employment, education) were key to treatment success.
1736 - - **Race and pre-existing substance use patterns** influenced completion rates.
1737 -
1738 -2. **Subgroup Trends:**
1739 - - White offenders had **higher completion rates** than Black offenders.
1740 - - Drug court success was **higher for those with lower initial drug use frequency**.
1741 -
1742 -3. **Specific Case Analysis:**
1743 - - **Individuals with strong social ties were more likely to finish the program**.
1744 - - Success rates were **significantly higher for participants with case management support**.
1745 -
1746 ----
1747 -
1748 -## **Critique and Observations**
1749 -1. **Strengths of the Study:**
1750 - - **First empirical study on drug court program success factors**.
1751 - - Uses **longitudinal data** for post-treatment analysis.
1752 -
1753 -2. **Limitations of the Study:**
1754 - - Lacks **qualitative data on personal motivation and treatment engagement**.
1755 - - Focuses on **short-term program success** without tracking **long-term relapse rates**.
1756 -
1757 -3. **Suggestions for Improvement:**
1758 - - Future research should examine **racial disparities in drug court outcomes**.
1759 - - Study **how community resources impact long-term recovery**.
1760 -
1761 ----
1762 -
1763 -## **Relevance to Subproject**
1764 -- Provides insight into **what factors contribute to drug court program success**.
1765 -- Highlights **racial disparities in criminal justice-based rehabilitation programs**.
1766 -- Supports **policy discussions on improving access to drug treatment for marginalized groups**.
1767 -
1768 ----
1769 -
1770 -## **Suggestions for Further Exploration**
1771 -1. Investigate **the role of mental health in drug court success rates**.
1772 -2. Assess **long-term relapse prevention strategies post-treatment**.
1773 -3. Explore **alternative diversion programs beyond traditional drug courts**.
1774 -
1775 ----
1776 -
1777 -## **Summary of Research Study**
1778 -This study examines **factors influencing the completion of drug treatment court programs**, identifying **employment, education, and race as key predictors**. The research underscores **systemic disparities in drug court outcomes**, emphasizing the need for **improved support systems for at-risk populations**.
1779 -
1780 -This summary provides an accessible, at-a-glance overview of the study’s contributions. Please refer to the full paper for in-depth analysis.
1781 -
1782 ----
1783 -
1784 -## **📄 Download Full Study**
1785 -[[Download Full Study>>attach:10.1081_JA-120014424.pdf]]
1786 -
1787 -{{/expand}}
1788 -
1789 -{{html}}<hr style="border: 3px solid red;">{{/html}}
1790 -